RSS-Feed abonnieren
DOI: 10.1055/a-2551-4541
Chiral Silver Alkoxide Catalyzed Asymmetric Mannich-Type Reaction of Alkenyl Esters with Isatin Imines
This work was supported by MEXT/JSPS KAKENHI (Grant Numbers 16K05766 and 19K05450). We gratefully acknowledge the financial support from Nippon Chemical Industrial Co., Ltd.

Abstract
A catalytic enantioselective Mannich-type reaction of alkenyl esters with isatin imines was achieved by using a Tol-BINAP·AgSbF6 complex as the chiral precatalyst and N,N-diisopropylethylamine as the base precatalyst in the presence of methanol. Optically active 3-alkylated 3-amino-2-oxindoles having up to 98% ee were diastereoselectively obtained in moderate to high yields not only from acyclic alkenyl esters but also from cyclic esters through the in situ generated chiral silver enolates.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-2551-4541.
- Supporting Information
Publikationsverlauf
Eingereicht: 26. Dezember 2024
Angenommen nach Revision: 05. März 2025
Accepted Manuscript online:
05. März 2025
Artikel online veröffentlicht:
10. April 2025
© 2025. Thieme. All rights reserved
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References and Notes
- 1 Kitamura H, Kato A, Esaki T. Eur. J. Pharmacol. 2001; 418: 225
- 2 Hara N, Nakamura S, Sano M, Tamura R, Funahashi Y, Shibata N. Chem. Eur. J. 2012; 18: 9276
- 3a Singh GS, Desta ZY. Chem. Rev. 2012; 112: 6104
- 3b Chauhan P, Chimni SS. Tetrahedron: Asymmetry 2013; 24: 343
- 3c Ziarani GM, Moradi R, Lashgari N. Tetrahedron: Asymmetry 2015; 26: 517
- 3d Yu J.-S, Zhou F, Liu Y.-L, Zhou J. Synlett 2015; 26: 2491
- 3e Kaur J, Chimni SS. Org. Biomol. Chem. 2018; 16: 3328
- 3f Ziarani GM, Moradi R, Lashgari N. Tetrahedron 2018; 74: 1323
- 3g Brandão P, Burke AJ. Tetrahedron 2018; 74: 4927
- 3h Egorov IN, Santra S, Kopchuk DS, Kovalev IS, Zyryanov GV, Majee A, Ranu BC, Rusinov VL, Chupakhin ON. Adv. Synth. Catal. 2020; 362: 4293
- 3i Hou X.-Q, Du D.-M. Adv. Synth. Catal. 2020; 362: 4487
- 3j Yasukawa N, Nakamura S. Chem. Commun. 2023; 59: 8343
- 4a Yan W, Wang D, Feng J, Li P, Zhao D, Wang R. Org. Lett. 2012; 14: 2512
- 4b Li T.-Z, Wang X.-B, Sha F, Wu X.-Y. J. Org. Chem. 2014; 79: 4332
- 4c Liu T, Liu W, Li X, Peng F, Shao Z. J. Org. Chem. 2015; 80: 4950
- 4d Engl OD, Fritz SP, Wennemers H. Angew. Chem. Int. Ed. 2015; 54: 8193
- 4e Gajulapalli VP. R, Jafari E, Kundu DS, Mahajan S, Peuronen A, Rissanen K, Enders D. Synthesis 2017; 49: 4986
- 4f Sivamuthuraman K, Kesavan V. J. Org. Chem. 2018; 83: 8936
- 4g Xu H, Kang T.-C, Sha F, Wu X.-Y. Org. Biomol. Chem. 2018; 16: 5780
- 4h Liu Y, Wang J, Wei Z, Cao J, Liang D, Lin Y, Duan H. Org. Biomol. Chem. 2018; 16: 8927
- 4i Chang Z, Ye C, Fu J, Chigumbu P, Zeng X, Wang Y, Jiang C, Han X. Adv. Synth. Catal. 2019; 361: 5516
- 4j Franc M, Urban M, Císařová I, Veselý J. Org. Biomol. Chem. 2019; 17: 7309
- 4k Rodríguez-Ferrer P, Sanz-Novo M, Maestro A, Andrés JM, Pedrosa R. Adv. Synth. Catal. 2019; 361: 3645
- 4l Zhu W.-R, Liu K, Weng J, Huang W.-H, Huang W.-J, Chen Q, Lin N, Lu G. Org. Lett. 2020; 22: 5014
- 4m Kaur J, Kaur BP, Islam N, Chauhan P, Chimni SS. Eur. J. Org. Chem. 2021; 5193
- 5a Wang X.-B, Li T.-Z, Sha F, Wu X.-Y. Eur. J. Org. Chem. 2014; 739
- 5b Kaur J, Kumari A, Bhardwaj VK, Chimni SS. Adv. Synth. Catal. 2017; 359: 1725
- 5c İşibol D, Karahan S, Tanyeli C. Tetrahedron Lett. 2018; 59: 541
- 5d Ričko S, Meden A, Ciber L, Štefane B, Požgan F, Svete J, Grošelj U. Adv. Synth. Catal. 2018; 360: 1072
- 5e Zhao B.-L, Du D.-M. Org. Lett. 2018; 20: 3797
- 5f Li B.-Y, Du D.-M. Adv. Synth. Catal. 2018; 360: 3164
- 5g Huang Q, Zhang L, Cheng Y, Li P, Li W. Adv. Synth. Catal. 2018; 360: 3266
- 5h Wu G, Xu H, Liu Z, Liu Y, Yang X, Zhang X, Huang Y. Org. Lett. 2019; 21: 7708
- 5i Karahan S, Tanyeli C. Org. Biomol. Chem. 2020; 18: 479
- 5j Li Z, Peng J, He C, Xu J, Ren H. J. Org. Chem. 2020; 85: 3894
- 5k Urban M, Nigríni M, Císařová I, Veselý J. J. Org. Chem. 2021; 86: 18139
- 5l Torán R, Puchán D, Sanz-Marco A, Vila C, Pedro JR, Blay G. Org. Biomol. Chem. 2022; 20: 8395
- 6a Guo Q.-X, Liu Y.-W, Li X.-C, Zhong L.-Z, Peng Y.-G. J. Org. Chem. 2012; 77: 3589
- 6b Tang Z, Shi Y, Mao H, Zhu X, Li W, Cheng Y, Zheng W.-H, Zhu C. Org. Biomol. Chem. 2014; 12: 6085
- 6c Wang Y, Shi F, Yao X.-X, Sun M, Dong L, Tu S.-J. Chem. Eur. J. 2014; 20: 15047
- 6d Bai M, Cui B.-D, Zuo J, Zhao J.-Q, You Y, Chen Y.-Z, Xu X.-Y, Zhang X.-M, Yuan W.-C. Tetrahedron 2015; 71: 949
- 6e Zhu Y, Zhang E, Luo C, Li X, Cheng J.-P. Tetrahedron 2015; 71: 4090
- 6f Dai J, Xiong D, Yuan T, Liu J, Chen T, Shao Z. Angew. Chem. Int. Ed. 2017; 56: 12697
- 6g Hajra S, Laskar S, Jana B. Chem. Eur. J. 2019; 25: 14688
- 6h Li G, Liu M, Zou S, Feng X, Lin L. Org. Lett. 2020; 22: 8708
- 6i Zhao M, Zhao Z, Wei Z, Cao J, Liang D, Lin Y, Duan H. J. Org. Chem. 2024; 89: 4474
- 7a Liu X, Zhang J, Zhao L, Ma S, Yang D, Yan W, Wang R. J. Org. Chem. 2015; 80: 12651
- 7b Lin H, Zhou Z, Cai J, Han B, Gong L, Meggers E. J. Org. Chem. 2017; 82: 6457
- 7c Sawa M, Miyazaki S, Yonesaki R, Morimoto H, Ohshima T. Org. Lett. 2018; 20: 5393
- 7d Yu J.-S, Noda H, Kumagai N, Shibasaki M. Synlett 2019; 30: 488
- 7e Fan Y, Lu J, Sha F, Li Q, Wu X.-Y. J. Org. Chem. 2019; 84: 11639
- 7f Shen Y.-B, Qian H.-L, Yang L, Zhou S, Rao H.-W, Wang Z.-H, You Y, Zhang Y.-P, Yin J.-Q, Zhao J.-Q, Zhang W, Yuan W.-C. Org. Lett. 2024; 26: 1699
- 8 Yanagisawa A, Lin Y, Miyake R, Yoshida K. Org. Lett. 2014; 16: 86
- 9a Gil J, Medio-Simon M, Mancha G, Asensio G. Eur. J. Org. Chem. 2005; 1561
- 9b Claraz A, Leroy J, Oudeyer S, Levacher V. J. Org. Chem. 2011; 76: 6457
- 10a Yanagisawa A, Kageyama H, Nakatsuka Y, Asakawa K, Matsumoto Y, Yamamoto H. Angew. Chem. Int. Ed. 1999; 38: 3701
- 10b Yanagisawa A, Nakatsuka Y, Asakawa K, Kageyama H, Yamamoto H. Synlett 2001; 69
- 10c Yanagisawa A, Nakatsuka Y, Asakawa K, Wadamoto M, Kageyama H, Yamamoto H. Bull. Chem. Soc. Jpn. 2001; 74: 1477
- 11 Asymmetric Mannich-Type Reaction Catalyzed by (R)-Tol-BINAP·AgSbF6 and (i-Pr)2NEt; Typical Procedure: Synthesis of 1-Benzyl-3-((4-bromophenyl)amino)-3-(1-oxo-1-phenylpropan-2-yl)indolin-2-one (3aa) A mixture of AgSbF6 (27.5 mg, 0.08 mmol), (R)-Tol-BINAP (27.2 mg, 0.04 mmol), and isatin imine 2a (195.6 mg, 0.5 mmol) was dissolved in anhydrous THF (6 mL) under an argon atmosphere and with direct light excluded, and stirred at room temperature for 20 min. To the resulting solution were added CH3OH (40.6 μL, 1.0 mmol) and (i-Pr)2NEt (17 μL, 0.10 mmol) successively at –40 °C. The mixture was stirred at that temperature for 5 min, then alkenyl trifluoroacetate 1a (142.0 μL, 0.75 mmol) was added dropwise to the resulting solution at –40 °C. After stirring for 1.5 h at that temperature, the mixture was treated with MeOH (3 mL). The mixture was then filtered through a glass filter funnel filled with Celite®, washed with EtOAc, and the combined filtrate and washes were concentrated in vacuo. The residual crude product was purified by column chromatography on silica gel to give the corresponding β-amino ketone 3aa (255.7 mg, 97% yield). The diastereomeric ratio was determined to be 92:8 by 1H NMR analysis. The enantiomeric ratio of the major isomer was determined to be 86% ee by HPLC analysis using a chiral column [Daicel Chiralpak AD-3, hexane–i-PrOH (4:1), flow rate = 1.0 mL/min] t 1 = 17.9 min (minor), t 2 = 117.6 min (major). The enantiomeric ratio of the minor isomer was determined to be 4% ee by HPLC analysis using a chiral column [Daicel Chiralpak AD-3, hexane–i-PrOH (4:1), flow rate = 1.0 mL/min] t 1 = 35.7 min (major), t 2 = 64.0 min (minor). [α]21.4 D +44.2 (c 1.0, CHCl3, 86% ee); mp 48–53 °C. 1H NMR (392 MHz, CDCl3): δ = 7.90 (d, J = 7.1 Hz, 2 H), 7.53–7.62 (m, 2 H), 7.46 (t, J = 8.2 Hz, 2 H), 7.26–7.28 (m, 4 H), 7.14 (m, 2 H), 7.06 (t, J = 7.9 Hz, 1 H), 6.98 (d, J = 8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 1 H), 6.13 (dt, J = 9.0, 2.5 Hz, 2 H), 5.59 (s, 1 H), 4.94 (d, J = 15.3 Hz, 1 H), 4.77 (d, J = 15.7 Hz, 1 H), 3.93 (q, J = 7.4 Hz, 1 H), 1.34 (d, J = 7.0 Hz, 3 H). 13C NMR (99 MHz, CDCl3): δ = 202.5, 176.8, 144.3, 142.4, 137.3, 135.5, 133.5, 131.6 (2C), 129.6, 128.8 (2C), 128.7 (2C), 128.2 (2C), 127.80, 127.75 (2C), 127.6, 126.2, 122.9, 118.9 (2C), 112.2, 109.7, 67.5, 45.1, 44.1, 13.0. IR (neat): 3341, 1715, 1593, 1486, 1465, 1343, 1259, 1211, 1173, 1075, 1001, 974 cm–1. MS (ESI): m/z [M]+ calcd for [C30H25O2N2Br]+: 524.1094; found: 524.1084.
- 12 The use of a small amount of MeOH decreased the rate of methanolysis of silver amide 5, resulting low yield of the desired product 3, while an excess amount of MeOH accelerated protonation of the chiral silver enolate 4 and reduced the yield of 3.
- 13a Edworthy IS, Rodden M, Mungur SA, Davis KM, Blake AJ, Wilson C, Schröder M, Arnold PL. J. Organomet. Chem. 2005; 690: 5710
- 13b Reisinger A, Himmel D, Krossing I. Angew. Chem. Int. Ed. 2006; 45: 6997
- 14 The relative and absolute stereochemistry of the Mannich products has not yet been determined.
For reviews on the reactions of isatin imines, see:
For examples using chiral thiourea organocatalysts, see:
For examples using chiral squaramide organocatalysts, see:
For examples using other chiral organocatalysts, see:
In our previous study on the chiral silver(I)-catalyzed asymmetric allylation of aldehydes, we showed that a considerable amount of an inert 2:1 complex of BINAP/silver(I) salt was formed, accompanied by a reactive 1:1 complex, when BINAP was added to an equimolar amount of the silver salt in MeOH. In the reaction, a 0.6:1 mixture of BINAP/silver(I) salt was found to produce the desired 1:1 complex without the formation of the 2:1 complex:
Two examples of the synthesis of achiral silver alkoxides have been reported, see: